Submitted by admin on September 24, 2018 - 10:23am
AZ’s Farxiga meets an endpoints in large CV outcomes trial
FDA lifts clinical hold on Sarepta’s DMD therapy
Amarin soars on positive Vascepa stroke prevention data
Gilead to launch generic versions of Epclusa and Harvoni
*please scroll down for all the latest news*
*scroll through previous pages at the bottom to get older news*
Today's most popular searches:
For banking news and anonymous forums, be sure to check out cafebanking.com
